Gene therapy strategies for hepatocellular carcinoma

Area of Science:

• Hepatocellular carcinoma (HCC) research
• Gene therapy applications
• Oncology therapeutics

Background:

• Hepatocellular carcinoma (HCC) is a globally prevalent cancer with limited effective treatment options.
• There is a significant unmet need for novel therapeutic strategies to manage HCC.
• Gene therapy presents a potential avenue for developing new treatments for liver cancer.

Purpose of the Study:

• To explore the potential of gene therapy as a therapeutic strategy for hepatocellular carcinoma (HCC).
• To review various gene therapy approaches being investigated for HCC treatment.
• To highlight the promise of gene therapy in controlling liver tumor growth.

Main Methods:

• Review of gene therapy strategies including apoptotic genes, suicide genes, antiangiogenic factors, immunomodulatory molecules, small interfering RNA (siRNA), and oncolytic viral vectors.
• Evaluation of these strategies in animal models of HCC and liver metastasis.
• Assessment of the combination of different vectors and therapeutic genes.

Main Results:

• Gene therapy approaches have shown promise in preclinical studies for HCC.
• Diverse gene therapy vectors and genes, used individually or in combination, are being investigated.
• These strategies have demonstrated potential in controlling tumor growth in liver cancer models.

Conclusions:

• Gene therapy represents a promising strategy for the development of novel treatments for hepatocellular carcinoma (HCC).
• The use of various genetic materials and delivery vectors offers a versatile approach to combat liver cancer.
• Further research and clinical translation of gene therapy hold potential for improving HCC patient outcomes.